{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:13:26Z","timestamp":1792815206881,"version":"4.5.0"},"reference-count":20,"publisher":"Centers for Disease Control MMWR Office","issue":"35","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm6935a1","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T14:27:29Z","timestamp":1599143249000},"page":"1189-1197","source":"Crossref","is-referenced-by-count":233,"title":["<i>Vital Signs:<\/i> Characteristics of Drug Overdose Deaths Involving Opioids and Stimulants \u2014 24 States and the District of Columbia, January\u2013June 2019"],"prefix":"10.15585","volume":"69","author":[{"given":"Julie","family":"O\u2019Donnell","sequence":"first","affiliation":[{"name":"Division of Overdose Prevention, National Center for Injury Prevention and Control, CDC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Matt","family":"Gladden","sequence":"additional","affiliation":[{"name":"Division of Overdose Prevention, National Center for Injury Prevention and Control, CDC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Mattson","sequence":"additional","affiliation":[{"name":"Division of Overdose Prevention, National Center for Injury Prevention and Control, CDC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calli T.","family":"Hunter","sequence":"additional","affiliation":[{"name":"Division of Overdose Prevention, National Center for Injury Prevention and Control, CDC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.","family":"Davis","sequence":"additional","affiliation":[{"name":"Division of Overdose Prevention, National Center for Injury Prevention and Control, CDC."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R1","unstructured":"Hedegaard H, Mini\u00f1o AM, Warner M. Drug overdose deaths in the United States, 1999\u20132018. NCHS data brief, no. 356. Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics; 2020. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db356.htm"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2017\u20132018.","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.15585\/mmwr.mm6834a2","article-title":"Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine\u201425 states, July\u2013December 2017 to January\u2013June 2018.","volume":"68","author":"Gladden","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.15585\/mmwr.mm6817a3","article-title":"Drug overdose deaths involving cocaine and psychostimulants with abuse potential\u2014United States, 2003\u20132017.","volume":"68","author":"Kariisa","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R5","doi-asserted-by":"publisher","first-page":"382","DOI":"10.15585\/mmwr.mm6614a2","article-title":"Characteristics of fentanyl overdose\u2014Massachusetts, 2014\u20132016.","volume":"66","author":"Somerville","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/2042098617744161","article-title":"Naloxone dosage for opioid reversal: current evidence and clinical implications.","volume":"9","author":"Rzasa Lynn","year":"2018","journal-title":"Ther Adv Drug Saf"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R7","unstructured":"CDC. Evidence-based strategies for preventing opioid overdose: what\u2019s working in the United States. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https:\/\/www.cdc.gov\/drugoverdose\/pdf\/pubs\/2018-evidence-based-strategies.pdf"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R8","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1038\/s41380-018-0094-5","article-title":"Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis.","volume":"24","author":"Ma","year":"2019","journal-title":"Mol Psychiatry"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R9","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.annemergmed.2018.01.052","article-title":"Opportunities for prevention and intervention of opioid overdose in the emergency department.","volume":"71","author":"Houry","year":"2018","journal-title":"Ann Emerg Med"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R10","doi-asserted-by":"publisher","first-page":"e1003002","DOI":"10.1371\/journal.pmed.1003002","article-title":"Opioid-related treatment, interventions, and outcomes among incarcerated persons: a systematic review.","volume":"16","author":"Malta","year":"2019","journal-title":"PLoS Med"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R11","doi-asserted-by":"crossref","unstructured":"Yule AM, Kelly JF. Integrating treatment for co-occurring mental health conditions. Alcohol Res 2019;40:07. 10.35946\/arcr.v40.1.0731649837","DOI":"10.35946\/arcr.v40.1.07"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R12","doi-asserted-by":"publisher","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fphar.2019.00238","article-title":"Metabolic pathways and potencies of new fentanyl analogs.","volume":"10","author":"Wilde","year":"2019","journal-title":"Front Pharmacol"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3978\/j.issn.2224-5820.2012.01.01","article-title":"Rapid onset opioids in palliative medicine.","volume":"1","author":"Smith","year":"2012","journal-title":"Ann Palliat Med"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugpo.2019.04.006","article-title":"Syringe services programs: an examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the U.S.","volume":"70","author":"Jones","year":"2019","journal-title":"Int J Drug Policy"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R16","doi-asserted-by":"publisher","first-page":"799","DOI":"10.15288\/jsad.2018.79.799","article-title":"Polysubstance use by stimulant users: health outcomes over three years.","volume":"79","author":"Timko","year":"2018","journal-title":"J Stud Alcohol Drugs"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R17","doi-asserted-by":"publisher","first-page":"e0234809","DOI":"10.1371\/journal.pone.0234809","article-title":"Treatment of stimulant use disorder: a systematic review of reviews.","volume":"15","author":"Ronsley","year":"2020","journal-title":"PLoS One"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2105\/AJPH.2019.305527","article-title":". Resurgent methamphetamine use at treatment admission in the United States, 2008\u20132017.","volume":"110","author":"Jones","year":"2020","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/15504263.2018.1518553","article-title":"A review of integrated care for concurrent disorders: cost effectiveness and clinical outcomes.","volume":"15","author":"Karapareddy","year":"2019","journal-title":"J Dual Diagn"},{"key":"key-10.15585\/mmwr.mm6935a1-202009031020-R20","unstructured":"Hedegaard H, Bastian BA, Trinidad JP, Spencer MR, Warner M. Regional differences in the drugs most frequently involved in drug overdose deaths: United States, 2017. National Vital Statistics Reports, vol. 68 no. 12. Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics. 2019. https:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr68\/nvsr68_12-508.pdf"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T14:27:42Z","timestamp":1599143262000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/69\/wr\/mm6935a1.htm?s_cid=mm6935a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":20,"journal-issue":{"issue":"35","published-online":{"date-parts":[[2020,9,4]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm6935a1","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9,4]]},"published":{"date-parts":[[2020,9,4]]}}}